Lanean...
Personalized Cancer Medicine: Are We There Yet?
Personalized cancer medicine is at a crucial phase of development. This month's edition focuses on how innovation and the development of personalized medicine can positively influence disease outcomes–but at what price?
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AlphaMed Press
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063386/ https://ncbi.nlm.nih.gov/pubmed/23814159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0189 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|